Role of the reticuloendothelial system in the catabolism of low density lipoprotein in the rat.
The role of the reticuloendothelial system (RES) in receptor-independent catabolism of human low density lipoprotein (h-LDL) was evaluated in the rat in vivo after blockade of its phagocytic activity with gadolinium chloride (GaCl3). After blockade of the RES with GaCl3, the recovery of [125I] h-LDL in the liver of 17 alpha-ethinyl oestradiol-treated rats (EE-rats), was decreased by 37 and 16%, 15 and 60 min after h-LDL injection, respectively. This decrease did not result in a decreased LDL degradation which represented 14 and 55% of the injected dose in the two groups of rats after 15 and 60 min respectively, both on GaCl3 and control rats. Contrasting with EE-rats, the catabolism of h-LDL in untreated rats is much slower and takes place essentially through a receptor-independent mechanism. Six hours after the injection of [125I] h-LDL, 64% of the dose was degraded. This proportion decreased to 45% after blockade of the RES phagocytic activity. This 30 percent difference represents the proportion of h-LDL catabolized by receptor-independent mechanisms present in the Küpffer and endothelial cells. We conclude from our study that in the normal rat, the parenchymal cells of the liver on the one hand and the Küpffer and endothelial cells on the other hand contribute 70 and 30% respectively to the receptor-independent catabolism of low density lipoproteins in vivo.
D000818:Animals; D004958:Estradiol / Q000494:pharmacology; D005682:Gadolinium / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D012157:Mononuclear Phagocyte System / Q000378:metabolism*; D010587:Phagocytosis / Q000187:drug effects; D051381:Rats; D011973:Receptors, LDL / Q000187:drug effects
D008077:Lipoproteins, LDL; D011973:Receptors, LDL; D004958:Estradiol; D005682:Gadolinium